Binding of terbium and cisplatin to C13@, human ovarian cancer cells using time-resolved terbium luminescence

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1448, Issue 1, 1998, Pages 85-98

  Canada, Robert G ^a   Paltoo, Dina N ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

C13; Cisplatin; Ovarian cell; Terbium luminescence

Indexed keywords

CARBON 13; CISPLATIN; TERBIUM;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; COMPLEX FORMATION; DIFFUSION; ELECTRON; ENERGY TRANSFER; HUMAN; HUMAN CELL; LUMINESCENCE; MATHEMATICAL ANALYSIS; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BINDING SITES; BIOLOGICAL TRANSPORT; CHEMILUMINESCENT MEASUREMENTS; CISPLATIN; DRUG INTERACTIONS; DRUG RESISTANCE; FEMALE; HUMANS; MODELS, THEORETICAL; OVARIAN NEOPLASMS; SPECTROMETRY, FLUORESCENCE; TERBIUM;

EID: 0032547986     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(98)00127-X     Document Type: Article

References (51)

1. Timmer-Bosscha H., Mulder N.H., de Vries E.G.E. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br. J. Cancer. 66:1992;227-238.
2. P.A. Andrews, Mechanisms of acquired resistance to cisplatin, in: L.J. Goldstein, R.F. Ozols (Eds.), Anticancer Drug Resistance: Advances in Molecular and Clinical Research, Kluwer Academic, Boston, 1994, pp. 217-248.
3. Perez R.P., Hamilton T.C., Ozols R.F., Young R.C. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer. Cancer. 71:1993;1571-1580.
4. Jekunen A.P., Shalinsky D.R., Hom D.K., Albright K.D., Heath D., Howell B.S. Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem. Pharmacol. 45:1993;2079-2085.
5. Onoda J.M., Jacobs J.R., Taylor J.D., Sloane B.F., Honn K.V. Cisplatin and nifedipine: Synergistic cytotoxicity against murine solid tumors and their metastases. Cancer Lett. 30:1986;181-188.
6. Onoda J.M., Nelson K.K., Taylor J.D., Honn K.V. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II). Cancer Res. 49:1989;2844-2850.
7. Ormerod M.G., O'Neill C.F., Robertson D., Harrap K.R. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res. 211:1994;231-237.
8. Havrilesky L.J., Elbendary A., Hurteau J.A., Whitaker R.S., Rodriguez G.C., Berchuck A. Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet. Gynecol. 85:1995;1007-1010.
9. Meyn R.E., Stephens L.C., Hunter N.R., Milas L. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int. J. Cancer. 60:1995;725-729.
10. Kondo S., Dali D.Y., Morimura T., Takeuchi J. Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells. J. Neurosurg. 82:1995;469-474.
11. Canada R.G. Terbium fluorescence studies of cisplatin binding to GH3/B6 pituitary tumor cells. Biochim. Biophys. Acta. 887:1986;29-34.
12. Mack K.M., Canada R.G., Andrews P.A. The effects of terbium on the accumulation of cisplatin in MDA-MB-231 human breast tumor cells. Cancer Chemother. Pharmacol. 39:1997;217-222.
13. 3+ in human breast cancer cells via the terbium-cisplatin binding protein. Biophys. J. 74:1998;A88.
14. D.N. Paltoo, R.G. Canada, Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma, Cancer Biochem. Biophys. 16 (1998) in press.
15. Canada R.G., Paltoo D.N. Time-resolved terbium luminescence studies of the calcium receptor binding of cisplatin in human ovarian cancer cells. Biophys. J. 70:1996;A211.
16. Canada R.G., Andrews P.A., Mack K.M., Haider A. The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells. Biochim. Biophys. Acta. 1267:1995;25-30.
17. Lansman J.B. Blockade of current through single calcium channels by trivalent lanthanide cations. J. Gen. Physiol. 95:1990;679-696.
18. Millelson R.B. Lanthanides as calcium probes in biomembranes. Biol. Membr. 3:1976;158-190.
19. Martin R.B., Richardson F.S. Lanthanides as probes for calcium in biological systems. Q. Rev. Biophys. 12:1979;181-209.
20. C.H. Evans, Biochemistry of the Lanthanides, Plenum Press, New York, 1990.
21. Canada R.G. Terbium binding to neoplastic GH3 pituitary cells. Biochem. Biophys. Res. Commun. 111:1983;135-142.
22. Canada R.G., Carpentier R.G. Physicochemical characteristics of the terbium-adriamycin complex and its effects on the sinus node automaticity. Biochim. Biophys. Acta. 1073:1991;136-141.
23. Gately D., Howell S. Cellular accumulation of the anticancer agent cisplatin: a review. Br. J. Cancer. 67:1993;1171-1176.
24. Andrews P.A., Murphy M.P., Howell S.B. Differential potentiation of alkylating and platinating agent toxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res. 45:1985;6250-6253.
25. Barela T.D., Sherry A.D. A simple, one-step fluorometric method for determination of nanomolar concentrations of terbium. Anal. Chem. 71:1976;351-357.
26. J.R. Lakowicz, Principles of Fluorescence Spectroscopy, Plenum Press, New York, 1983.
27. Kropp J.L., Windsor M.W. Luminescence and energy transfer in solutions of rare-earth complexes I. Enhancement of fluorescence by deuterium substitution . J. Chem. Phys. 42:1965;1599-1608.
28. Schlyer B.D., Steel D.G., Gafni A. Direct kinetic evidence for triplet state energy transfer from Escherichia coli alkaline phosphatase tryptophan 109 to bound terbium. J. Biol. Chem. 270:1995;22890-22894.
29. McNemar L.S., Lin W.Y., Eada C.D., Atkins W.M., Dombrosky P., Villafranca J.J. Terbium(III) luminescence study of the spatial relationship of tryptophan residues to the two metal ion binding sites of Escherichia coli glutamine synthetase. Biochemistry. 30:1991;3417-3421.
30. De Jersey J., Morley P.J., Martin R.B. Lanthanide probes in biological systems: Characterization of luminescence excitation spectra of terbium complexes with proteins. Biophys. Chem. 13:1981;233-243.
31. R.F. Chen, H. Edelhoch, R.F. Steiner, Fluorescence of proteins, in: S.J. Leach (Ed.), Physical Principles and Techniques of Protein Chemistry - Part A, Academic Press, New York, 1969, pp. 171-244.
32. G.D. Fasman, Practical Handbook of Biochemistry and Molecular Biology, CRC Press, Boca Raton, FL, 1989.
33. Wallace R.W., Tallant E.A., Dockter M.E., Cheung W.Y. Calcium binding domains calmodulin, sequence of fill as determined with terbium luminescence. J. Biol. Chem. 257:1982;1845-1854.
34. Horrocks W.DeW., Collier W.E. Lanthanide ion luminescence probes of distance between intrinsic protein fluorophores and bound metal ions: Quantitation of energy transfer between tryptophan and terbium(III) or europium(III) in the calcium-binding protein parvalbumin. J. Am. Chem. Soc. 103:1981;2856-2862.
35. Horrocks W.DeW., Snyder A.P. Measurement of distance between fluorescent amino acid residues and metal ion binding sites. Quantitation of energy transfer between tryptophan and terbium(III) or europium(III) in thermolysin. Biochem. Biophys. Res. Commun. 100:1981;111-117.
36. Canada R.G. Terbium luminescence studies of binding of adriamycin and cisplatin to tumorigenic cells. Anal. Chim. Acta. 205:1988;77-87.
37. Horrocks W.DeW., Schmidt G.F., Sudnick D.R., Kittrell C., Bernheim R.A. Laser-induced lanthanide ion luminescence lifetime measurements by direct excitation of metal ion levels. A new class of structural probe for calcium-binding proteins and nucleic acids. J. Am. Chem. Soc. 99:1977;2378-2380.
38. Horrocks W.DeW., Sudnick R.D. Lanthanide ion probes of structure in biology. Laser-induced luminescence decay constants provide a direct measure of the number of metal-coordinated water molecules. J. Am. Chem. Soc. 101:1979;334-340.
39. O'Hara P.B. Lanthanide ions as luminescent probes of biomolecular structure. Photochem. Photobiol. 46:1987;1067-1070.
40. I.H. Segel, Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems, John Wiley, New York, 1975.
41. Veenstra T.D., Gross M.D., Hunziker W., Kumar R. Identification of metal-binding sites in rat brain calcium-binding protein. J. Biol. Chem. 270:1995;30353-30358.
42. Burstein E.A., Vedenkina N.S., Ivkova M.N. Fluorescence and the location of tryptophan residues in protein molecules. Photochem. Photobiol. 18:1973;263-279.
43. Simpkins H., Figliomeni M., Rosen M. The interaction of platinum and anthrapyrazole antitumor drugs with mouse thymocytes studied by terbium fluorescence. Biochim. Biophys. Acta. 972:1988;25-32.
44. Meares C.F., Yeh S.M., Stryer L. Exchange interaction contribution to energy transfer between ions in the rapid-diffusion limit. J. Am. Chem. Soc. 103:1981;1607-1609.
45. Stryer L., Thomas D.D., Meares C.F. Diffusion-enhanced fluorescence energy transfer. Annu. Rev. Biophys. Bioeng. 11:1982;203-222.
46. Canada R.G. Calcium receptor binding of cisplatin and terbium in human breast tumor cells after hyperthermia. Radiat. Res. 133:1993;170-175.
47. Bennett R.G., Schwenker R.P., Kellogg R.E. Radiationless intermolecular energy transfer II. Triplet→singlet transfer . J. Chem. Phys. 41:1964;3040-3041.
48. Kellogg R.E., Bennett R.G. Radiationless intermolecular energy transfer III. Determination of phosphorescence efficiencies . J. Chem. Phys. 41:1964;3042-3045.
49. Dougherty D.A. Cation-π interactions in chemistry and biology: a new view of benzene, phe, tyr, and trp. Science. 271:1996;163-168.
50. Rosenberg B. Fundamental studies with cisplatin. Cancer. 55:1985;2303-2316.
51. E. Reed, K.W. Kohn, in: B.A. Chabner (Ed.), Platinum Analogues: Chemotherapy Principles and Practice, Academic Press, New York, 1990, pp. 465-490.